Support through Mobile Messaging and digital health Technology for Diabetes
Type 2 diabetes affects 2.9 million people in the UK. Tablet medications which are taken to reduce risks of complications are effective if taken as intended but concerns about medicines and difficulties with taking them regularly are common. Between a third and half of the medicines used to treat this condition are not taken as prescribed.
There is some evidence that receiving brief text messages can help people to take their medications as prescribed and to manage their health condition. However, more research is needed to develop such messages, embed them in health care delivery systems, and test whether they work when used at a wide scale.
University of Manchester
This six-year study is funded by the National Institute for Health Research. Ethics Ref: 18/WS/0173
Check the map below to make sure your GP surgery is taking part in the study. If they're not taking part, let us know and we can contact them for you. Can't see the map? Click here.
If you are in the north of England, read the information sheet:
If you are in the south of England, read the information sheet:
In you are in the north of England, to join the study:
Text: 'Register' + your full name to 07422129245
If you are in the south of England, to join the study:
Text: 'Register' + your full name to 07422128690
We are recruiting!
- Patients over 35 years old who are taking tablet medication for their type 2 diabetes who have had a change in their tablet medication within the past three months will be invited to take part in SuMMiT-D.
- Patients will be randomly assigned to either the tailored messages (intervention) or general messages (control) groups.
- The tailored messages group will receive three text messages per week.
- The general message group will receive one message per month.
- Interested in joining the study? Check out the three easy steps for guidance.
Meet the team:
Patient and Public Contributor